This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Boehringer Ingelheim Vetmedica Gmbh, Other. Active years: 2015-2022.
Company Filing History:
2 out of 317 
1 out of 834,411 Years Active: 2015-2022
Title: Andrea Vollmar - Innovator in Heart Failure Treatment
Introduction
Andrea Vollmar is a distinguished inventor based in Wissen, Germany. She has made significant contributions to the field of medicine, particularly in the treatment of heart failure. With a total of 3 patents, her work focuses on innovative methods to improve patient outcomes.
Latest Patents
One of her latest patents involves PDE III inhibitors for the treatment of asymptomatic heart failure. This method includes administering a therapeutically effective amount of pimobendan or a pharmaceutically acceptable salt thereof, resulting in a reduction in the size of the patient's heart. Another patent details the use of phosphodiesterase type III (PDE III) inhibitors or 'Ca-sensitizing agents' in the preparation of medication aimed at reducing heart size and facilitating reverse remodeling in patients with asymptomatic heart failure.
Career Highlights
Throughout her career, Andrea has worked with notable companies, including Boehringer Ingelheim Vetmedica GmbH. Her expertise in the field has led to advancements in heart failure treatments, showcasing her commitment to improving healthcare.
Collaborations
Andrea has collaborated with esteemed colleagues such as Rainer Kleemann and Christian Troetschel, contributing to her innovative research and development efforts.
Conclusion
Andrea Vollmar's contributions to the medical field, particularly in heart failure treatment, highlight her role as a leading inventor. Her patents and collaborations reflect her dedication to advancing healthcare solutions.